Abstract
New Entry to Australian Stock Exchange: Acrux. Peplin's Phase I Clinical Trial Completed. Prima BioMed & AstraZeneca in Licensing Agreement. Ultratech India Restrained from Tampering with Pfizer's Viagra Trademarks. India Offers Competitive New Drug Solutions. Rofecoxib Formulation Discontinued after Health Ministry's Ban. GSK Focuses on In-licensing for Other Global Companies in India. Forthcoming Pharmaceutical Hub in Bengal. Upcoming Medical Industry Zone in Japan. Roche and Japan Tobacco in Licensing Collaboration for Potential Dyslipidemia Therapy. Tapping on Nature for Drugs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
